Comprehensive Analysis of Hypermutation in Human Cancer
2017 · Cell · 772 citations
https://doi.org/10.1016/j.cell.2017.09.048
V
Vijay Ramaswamy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
655
Papers
26.9K
Citations
74
h-index
210
i10-index
Vijay Ramaswamy is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Hedgehog Signaling Pathway Studies & Neuroblastoma Research and Treatments. The author has an h-index of 74, co-authored 557 publications.
ORCID: 0000-0002-6557-895XPapers by this author
worksSubgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
2013 · Journal of Clinical Oncology · 474 citations
https://doi.org/10.1200/jco.2012.48.5052
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
2016 · The Lancet Oncology · 365 citations
https://doi.org/10.1016/s1470-2045(15)00581-1
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
2019 · Acta Neuropathologica · 292 citations
https://doi.org/10.1007/s00401-019-02020-0
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
2013 · Acta Neuropathologica · 285 citations
https://doi.org/10.1007/s00401-013-1126-5
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
2013 · Acta Neuropathologica · 163 citations
https://doi.org/10.1007/s00401-013-1198-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat